FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
批准号:
2523080
负责人:
NICHOLAS A CATALDO
金额:
$7.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-03-01 至 2001-02-28
关键词:
apoptosis binding proteins biological signal transduction complementary DNA egg /ovum epidermal growth factor female fibroblast growth factor gene expression granulosa cell human tissue inhibin insulinlike growth factor interferon gamma ligands luteinizing hormone menstrual cycle messenger RNA nucleic acid probes ovary disorder stainings steroid biosynthesis tissue /cell culture tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Candidate. The candidate has been trained in obstetrics and gynecology and
has completed a subspecialty fellowship in Reproductive Endocrinology. He
has been actively engaged in basic research on human granulosa cell
physiology for over 4 years and has experience with a number of the
techniques to be used in this proposal. He has published five first-author
papers, and another has been submitted (Appendix).
Research plan. During embryonic and fetal development, the number of
oocytes in the human ovary increases until mid-gestation, after which it
steadily declines until the menopause. Oocytes which are not surrounded by
granulosa cells nearly i ovarian development undergo atresia, while
follicles also undergo atresia at every stage of development from the
primordial to the tertiary antral stage. The vast majority of oocytes are
lost through atresia; only a minority mature to ovulation. In non-human
models, atresia of antral follicles has been associated with granulosa cell
apoptosis, or programmed cell death. Activation of apoptosis can be
regulated by both extracellular (cytokine, growth facto) and
intracellular mechanisms. The extracellular factors which regulate non-
human granulosa cell apoptosis are being reported. The proposed studies
seek to identify the intracellular pathways that signal the human granulosa
cell to undergo apoptosis, as well as the source and identity of th
extracellular effectors that activate the apoptotic signal through these
pathways. A better understanding of the process of granulosa cell
apoptosis may aid in the design of new therapies to retard the loss of
oocytes that accompanies both normal aging and therapies for malignancy.
The specific aims of this proposal are to investigate the roles of the
intracellular apoptosis-regulating molecules Fas/APO-1 and Bcl-2 in the
human ovary, as well as the roles of the cytokines interferon-gamma (IFN-
gamma) and tumor necrosis factor-alpha (TNF-alpha) in transmitting the
apoptotic signal. These studies may also help to determine whether the
apoptotic signal originates within ovarian parenchymal cells or from
leukocytes. It is hypothesized that in human granulosa cells, expression
and activation of Fas promotes apoptosis, while Bcl-2 expression in excess
of its antagonist Bax prevents apoptosis. It is further hypothesized that
IFN-gamma induces Fas expression, while TNF-alpha may induce apoptosis
through its own receptor.
Environment. The Reproductive Endocrinology Center at the university of
California, San Francisco is supported by NIH Grant #HD11979. Included in
the Center are Morphology, Molecular Biology, and Radioimmunoassay Cores,
the facilities of which are available to the investigator. The Primary
Sponsor's laboratory and these Cores contain all of the necessary equipment
for the studies proposed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROSIGLITAZONE AND CLOMIPHENE FOR OVULATION INDUCTION
-
批准号:7202018
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2004
-
负责人:NICHOLAS A CATALDO
-
依托单位:
Troglitazone and Clomiphene for Ovulation Induction
-
批准号:6980889
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2003
-
负责人:NICHOLAS A CATALDO
-
依托单位:
Rosiglitazone in Polycystic Ovary Syndrome
-
批准号:6980894
-
项目类别:
-
资助金额:$7.59万
-
财政年份:2003
-
负责人:NICHOLAS A CATALDO
-
依托单位:
Rosiglitazone and Clomiphene for Ovulation Induction
-
批准号:6399073
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2001
-
负责人:NICHOLAS A CATALDO
-
依托单位:
ROSIGLITAZONE IN POLYCYSTIC OVARY SYNDROME
-
批准号:6232505
-
项目类别:
-
资助金额:$5.58万
-
财政年份:2001
-
负责人:NICHOLAS A CATALDO
-
依托单位:
ROSIGLITAZONE IN POLYCYSTIC OVARY SYNDROME
-
批准号:6536264
-
项目类别:
-
资助金额:$5.55万
-
财政年份:2001
-
负责人:NICHOLAS A CATALDO
-
依托单位:
Rosiglitazone and Clomiphene for Ovulation Induction
-
批准号:6526395
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2001
-
负责人:NICHOLAS A CATALDO
-
依托单位:
TROGLITAZONE AND CLOMIPHENE FOR OVULATION INDUCTION
-
批准号:2677526
-
项目类别:
-
资助金额:$5.28万
-
财政年份:1998
-
负责人:NICHOLAS A CATALDO
-
依托单位:
FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
-
批准号:2668560
-
项目类别:
-
资助金额:$7.83万
-
财政年份:1996
-
负责人:NICHOLAS A CATALDO
-
依托单位:
FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
-
批准号:2194747
-
项目类别:
-
资助金额:$7.72万
-
财政年份:1996
-
负责人:NICHOLAS A CATALDO
-
依托单位:
FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
-
批准号:6164877
-
项目类别:
-
资助金额:$7.94万
-
财政年份:1996
-
负责人:NICHOLAS A CATALDO
-
依托单位:
FAS AND BC1-2 AND GRANULOSA CELL APOPTOSIS
-
批准号:2883108
-
项目类别:
-
资助金额:$7.88万
-
财政年份:1996
-
负责人:NICHOLAS A CATALDO
-
依托单位:
海外基金